Skip to main content

Table 5 Selected publications on disease control rates following postoperative (n > 300) and definitive IMRT (n = 63) in OCC

From: Follow up after IMRT in oral cavity cancer: update

Author [ref]

Center

Year

Interval

N

postop IMRT

CT

T3/4

N>/=2

lll/lV

LRC

D M F S

O A S

Postop

Definitive

Postop

Definitive

Postop

Definitive

Eisbruch et al [3]

U of MI

2004

1997-2002

27

most postop

na

na

na

na

59% (3y)

na

na

na

na

na

Yao et al [4]

U of Iowa

2007

2001-05

55

49 (89%)

11%

56%

36%

91%

85% (3y)

na

89% (3y)

na

68% (3y)

na

Studer et al [5]

U of Zurich

2007

2002-07

58

28 (48%)

78%

69%

28%

62%

91% (2y)

43% (2y)

95% (2y)

85% (2y)

83% (2y)

30% (2y), n = 30

Gomez et al [12]

MSKCC

2009

2000-06

35

35 (100%)

29%

40%

38%

80%

77% (3y)

none

85% (3y)

na

74% (3y)

none

Chen WC et al [13]

Chiayi, Taiwan

2009

2002-05

22

22 (100%)

na

na

7 (32%)

100%

64% (3y)

none

na

na

67% (3y)

none

Collan et al [14]

U of Helsinki

2011

2001-2007

40

40 (100%)

38%

na

na

na

na

none

na

na

75% (3y)

none

Sher D et al [15]

DFCI

2011

2004-09

42

30 (71%)

~76%

45%

30%

64%

91% (2y)

64% (2y)

94% (2y)

83% (2y)

85% (2y)

63% (2y), n = 12

Daly M et al [16]

Stanford UMC

2011

2002-09

37

30 (81%)

68%

54%

46%

57%

53% (3y)

60% (3y)

81% (3y)

71% (3y)

60% (3y)

57% (3y), n = 7

own cohort

U of Zurich

2012

2002-2011

160

99 (62%)

72%

40%

77%

68%

84% (4y)

40% (4y)

90% (4y)

85% (4y)

81% (4y)

38% (4y), n = 44

  1. (): included in the recent analysis.
  2. (): included all patients with R0-1 status (excluded 17 operated patients with macroscopic disease after surgery.
  3. U: University Hospital.
  4. MSKCC: Memorial Sloan-Kettering Cancer Center.
  5. DFCI: Dana-Farber Cancer institute.
  6. UMC: University Medical Center.
  7. CT: Chemotherapy.
  8. LRC: loco-regional control.
  9. DMFS: distant metastasis free survival.
  10. OAS: overall survival.